US-approved vaccines effective against B1617 Indian Covid variant: Official ...Middle East

COVID-19 vaccines approved by the United States like Pfizer, Moderna and Johnson and Johnson have effectiveness against the B1617 variant of the virus that is predominant in India, which is experiencing one of the worst outbreaks of the pandemic, a top American health official said. The observation is based on the latest data about the variant and the three major vaccines approved by the United States, said Dr Francis Collins, Director of National Institute of Science. The data is coming in, and it looks very encouraging that the U.S.-approved vaccines, the Pfizer, the Moderna, the J&J, do have effectiveness against this variant called B1617, Collins told the media. It's a little less effect

Hence then, the article about us approved vaccines effective against b1617 indian covid variant official was published today ( Thursday 13/05/2021 - 05:17 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( US-approved vaccines effective against B1617 Indian Covid variant: Official )

Also on site :

• VERNAL CAPITAL ACQUISITION CORP. ANNONCE LA FIXATION DU PRIX DU PREMIER APPEL PUBLIC À L'ÉPARGNE DE 100 MILLIONS DE DOLLARS
• NORDIC TECH LEADER TIETO OYJ SELECTS GEP'S AI-NATIVE SOFTWARE TO HELP TRANSFORM SOURCING AND PROCUREMENT
• Nelnet Campus Commerce Named Top Higher Education Payment Solutions Provider by Education Technology Insights